UAMS awarded $2.9M NIH grant to study immune evasion by cancer-linked herpesvirus
The National Institutes of Health (NIH) has granted the University of Arkansas for Medical Sciences (UAMS) a five-year $2.9 ...
Nasdaq19 天
Assembly Biosciences announces $30.1M investment, funding from Gilead
Funding received from Gilead will support the advancement of Assembly Bio’s clinical pipeline of antiviral therapeutic candidates for herpesviruses, hepatitis D virus and hepatitis B virus.